Clinical Trials on Glabellar Crease
Total 10000 results
-
Memorial Sloan Kettering Cancer CenterRecruitingBreast Cancer | Breast CarcinomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingBreast Neoplasm | Breast CarcinomaUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)Recruiting
-
PfizerCompletedBreast Cancer | Breast CarcinomaBrazil
-
Memorial Sloan Kettering Cancer CenterGRAIL, Inc.CompletedBreast Cancer | Breast BenignUnited States
-
Washington University School of MedicineAgency for Healthcare Research and Quality (AHRQ)Completed
-
Hospital Universitario 12 de OctubreCompleted
-
Uppsala UniversityCompletedBreast Cancer | Breast Neoplasms | Breast DiseaseSweden
-
Hope Rugo, MDGlaxoSmithKlineCompletedBreast Cancer | Breast NeoplasmUnited States
-
Zhejiang Cancer HospitalUnknownBreast Cancer | Breast Diseases | Neoplasm, BreastChina
-
Memorial Sloan Kettering Cancer CenterBristol-Myers SquibbCompletedBreast CancerUnited States
-
GE HealthcareTerminatedBreast Cancer | Tumors, BreastFrance, United States
-
GE HealthcareTerminatedBreast Cancer | Tumors, BreastUnited States
-
Brust-Zentrum AGCompleted
-
Roswell Park Cancer InstituteAstraZeneca; National Center for Complementary and Integrative Health (NCCIH)Completed
-
Susanne CrocamoCompletedNeoplasms | Neoplasms by Site | Breast Cancer | Breast DiseaseBrazil
-
University of MichiganNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedBreast CancersUnited States
-
Emory UniversityNovartis; Eisai Inc.TerminatedBreast Cancer | Breast Neoplasms | Breast TumorsUnited States
-
Centre Oscar LambretSysmex America, Inc.Unknown
-
Centre Francois BaclesseTerminated
-
AstraZenecaGerman Adjuvant Breast Cancer GroupCompleted
-
National Cancer Institute (NCI)CompletedBreast Cancer | Breast NeoplasmUnited States
-
University Hospital, ToursCompleted
-
Jonsson Comprehensive Cancer CenterNot yet recruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Invasive Breast Carcinoma | Localized Estrogen Receptor-Positive Breast Carcinoma | Localized Human Epidermal Growth Factor Receptor (HER2)-Negative Breast CarcinomaUnited States
-
Radionetics OncologyRecruitingHormone Receptor Positive Breast Adenocarcinoma | Locoregionally Recurrent Hormone-receptor Positive Breast Cancer | Metastatic Hormone Receptor Positive Breast CancerUnited States
-
BriaCell Therapeutics CorporationRecruitingBreast Cancer | Breast Neoplasm | Metastatic Breast Cancer | Breast Cancer Metastatic | End Stage CancerUnited States
-
Fred Hutchinson Cancer CenterNot yet recruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8United States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8United States
-
Fred Hutchinson Cancer CenterApex FoundationActive, not recruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8United States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Active, not recruitingBreast Cancer Stage I | Breast Cancer Stage II | Breast Cancer Stage IIIUnited States
-
Relay Therapeutics, Inc.CompletedBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Solid Tumor, Adult | HER2-negative Breast Cancer | Hormone Receptor Positive Tumor | Unresectable Solid Tumor | PIK3CA MutationUnited States
-
Seoul National University HospitalTerminatedMetaplastic Breast CarcinomaKorea, Republic of
-
iOMEDICO AGNovartis Pharmaceuticals; Arbeitsgemeinschaft fur Internistische OnkologieCompletedBreast Cancer Recurrent | HER2/Neu-negative Carcinoma of Breast | Hormone Receptor Positive Malignant Neoplasm of BreastGermany
-
Synta Pharmaceuticals Corp.CompletedBreast Cancer | Triple Negative Breast Cancer | HER-2 Positive Breast Cancer | ER/Progressive Response (PR) + Refractory to Prior Hormonal TreatmentSpain, United States, Argentina, Belgium, Brazil, Korea, Republic of, Peru, United Kingdom
-
Tianjin Medical University Cancer Institute and...Not yet recruitingAdvanced Breast Cancer | HER2 + Breast Cancer | HER2positiveChina
-
Atlas UniversityNot yet recruitingBreast Cancer | Locally Advanced Breast Cancer (LABC)Turkey (Türkiye)
-
University of Vermont Medical CenterNot yet recruitingBreast Cancer | HER-2 Positive Breast CancerUnited States
-
Norwegian Institute of Public HealthVestre Viken Hospital Trust; Oslo University Hospital; University Hospital, Akershus and other collaboratorsNot yet recruitingBreast Cancer | Risk Stratification | Mammographic Breast Density
-
Hoffmann-La RocheRecruitingMetastatic Breast Cancer | Locally Advanced Breast CancerChina
-
Portsmouth Hospitals NHS TrustUniversity of PortsmouthRecruitingBreast Cancer PatientsUnited Kingdom
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Not yet recruitingAdvanced Breast Cancer
-
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.Recruiting
-
Ana Trigueros MurilloNot yet recruitingBreast Cancer SurvivorsSpain
-
Fudan UniversityNot yet recruitingAdvanced Breast CancerChina
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruiting
-
Esbjerg Hospital - University Hospital of Southern...Odense University Hospital; Aarhus University Hospital; University of Copenhagen and other collaboratorsRecruitingEarly Breast CancerDenmark
-
European Institute of OncologyRecruitingMetastatic Breast CancerItaly
-
Baker Heart and Diabetes InstituteNot yet recruitingBreast Cancer SurvivorshipAustralia
-
Jan ŽateckýRecruitingBreast Cancer SurgeryCzech Republic
-
Cancer Institute and Hospital, Chinese Academy...Recruiting